Congressional disclosures
John Garamendi
Recent disclosures
9 of 9 on record · Jan 5, 2016 to Jan 14, 2022| Asset | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| SQSpouse | Stock | Sale | $1,001 - $15,000 | -34.8%S&P +28.6% · vs S&P 500 -63.4% | Jan 14, 2022 | Jan 21, 2022 | 7d |
| TWTRSpouseCommunication Services | Stock | Sale | $1,001 - $15,000 | +39.7%S&P -18.3% · vs S&P 500 +58.0% | Jan 14, 2022 | Jan 21, 2022 | 7d |
| FBMETA PLATFORMS, INC. - CLASS ASpouseCommunication Services | Stock | Sale | $15,001 - $50,000 | -86.4%S&P +64.1% · vs S&P 500 -150.4% | Jan 14, 2022 | Jan 21, 2022 | 7d |
| GVAGRANITE CONSTRUCTION INCORPORATEDSpouseIndustrials | Stock | Sale | $1,001 - $15,000 | +205.7%S&P +64.1% · vs S&P 500 +141.6% | Jan 14, 2022 | Jan 21, 2022 | 7d |
| HEALTH FUSIONJointFiled lateAs filed: PRIVATE PLACEMENT | Other | Sale | $15,001 - $50,000 | n/a | May 15, 2017 | Jul 23, 2017 | 69d |
| SZYMSOLAZYME, INC.SpouseFiled lateOther | Stock | Sale | $1,001 - $15,000 | n/a | Apr 21, 2017 | Jul 18, 2017 | 88d |
| HEALTHFUSIONJointFiled lateAs filed: SALE OF STOCK | Other | Sale | $15,001 - $50,000 | n/a | Jan 21, 2016 | Jul 18, 2017 | 544d |
| SZYMSOLAZYME, INC.JointFiled lateOther | Stock | Purchase | $1,001 - $15,000 | +6.2%S&P +8.7% · vs S&P 500 -2.5% | Jan 8, 2016 | Jul 18, 2017 | 557d |
| HEALTHFUSIONJointFiled lateAs filed: SALE OF STOCK OPTIONS. THESE WERE CREATED IN THE PROCESS OF THE SALE OF THE COMPANY. I WAS UNAWARE THAT THESE | Other | Sale | $250,001 - $500,000 | n/a | Jan 5, 2016 | Jul 18, 2017 | 560d |
No disclosures of that kind among the 9 rows shown.
Showing the 9 most recent disclosures. One row is one disclosure: a member filing for more than one account on the same day, in the same band, is counted once and marked.
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, with the S&P 500 over the same window and the difference against it. The numbers describe the stock after the trade, not the member's result: a disclosure carries a band, not a fill, and a sale keeps the same sign, so a positive number after a sale means the stock kept rising. An option row carries the underlying stock's move. Estimates; n/a on assets with no market price. Not investment advice.
Year by year
buy volume against sale volume · range midpointsDisclosed volume per year the member traded, 2016 to 2022. A filing gives a range, not an amount, so each bar sums the midpoints of the ranges disclosed that year: a $1,001 to $15,000 line counts as $8,000.
Where the disclosed portfolio sits
by weightGetSignal pushes each new disclosure to your phone as it lands, with the full history and every other member. Free on iOS and Android.
Questions
How many stock trades has John Garamendi disclosed?
John Garamendi has disclosed 9 transactions under the STOCK Act. This page lists the 9 most recent, covering Jan 5, 2016 to Jan 14, 2022.
How long does John Garamendi take to report a trade?
Across the disclosures shown here the median gap between the transaction and its publication is 69 days. The STOCK Act allows up to 45, so a delay inside that window is lawful.
Which stocks does John Garamendi trade most?
In the disclosures shown here the most frequent tickers are SZYM, FB, GVA, SQ, TWTR.
Which accounts do John Garamendi's disclosures name?
Of the 9 disclosures shown, 5 name a spouse's account and 4 a joint account. The account is whatever the filer wrote on the disclosure; a spouse's or a joint account is disclosed under the member's name, as the STOCK Act requires.
Where does the estimated net worth on this page come from?
It is an estimate produced by a model, not a figure the member disclosed. Congressional financial disclosure reports every asset and liability in a band rather than an amount, so the model takes a value within each band and nets the liabilities. It is shown to two figures because the largest band is open ended and a third would be arithmetic rather than information. It covers only what the disclosures carry, and it is not a measurement of anyone's wealth. The methodology page sets out how it is built and what it leaves out.
How have the stocks moved since John Garamendi's trades?
Across the 5 priced rows shown, the median stock move from the trade date to the latest close we hold (Sep 10, 2026) is +6.2%. That figure is an estimate describing the stock after each trade, not the member's result: a disclosure carries a band, not a fill, a sale keeps the same sign, and an option row carries the underlying stock's move. 4 of the rows shown have no market price.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
A disclosure is a record of a transaction, not evidence of anything else, and nothing here is investment advice. Sourcing and the limits of this data are on the methodology page.
Data as of Sep 10, 2026.